Sh6,000.00
Amoxiclav syrup 228/5, also known as Indiclav, is a combination medication that contains two active ingredients: amoxicillin and clavulanic acid. It is used to treat bacterial infections caused by susceptible organisms.
Some common uses of amoxiclav syrup 228/5 include:
| Settings | AMOXYCLAV SYR 228/5 INFUMOX 100ML remove | Action Tablets remove | Infacare #1 remove | Alatrol Syrup 30ml remove | Acefen Tablets remove | Ampicillin Syrup remove |
|---|---|---|---|---|---|---|
| Image |  |  |  |  |  |  |
| SKU | ||||||
| Rating | ||||||
| Price | Sh6,000.00 | Sh10,000.00 | Sh25,000.00 | Sh2,000.00 | Sh6,000.00 | Sh1,500.00 |
| Stock | ||||||
| Availability | ||||||
| Add to cart | ||||||
| Description | Amoxiclav syrup 228/5, also known as Indiclav, is a combination medication that contains two active ingredients: amoxicillin and clavulanic acid. It is used to treat bacterial infections caused by susceptible organisms. |
| ||||
| Content | Some common uses of amoxiclav syrup 228/5 include:
| Is a quality Aspirin, Paracetemol & Caffeine combination brand that promises quick relief from that pounding headache | Infacare Stage 1 Infant Starter Formula is a powdered infant milk formula that’s been scientifically formulated to help with the optimal growth of your baby from birth up to 6 months. | Alatrol Syrup contains Cetirizine which is an antihistamine used to relieve allergy symptoms such as watery eyes, runny nose, itching eyes/nose, sneezing, hives, and itching. It works by blocking a certain natural substance (histamine) that your body makes during an allergic reaction. | Acefen Tablet is a combination of Ibuprofen and Paracetamol, a pain-relieving medicine. | Ampicillin is a prescription penicillin-type antibiotic used to treat many different types of infections caused by bacteria, such as ear infections, bladder infections, pneumonia, gonorrhea, and E. coli or salmonella infection. |
| Weight | ||||||
| Dimensions | N/A | N/A | N/A | N/A | N/A | N/A |
| Additional information |
Reviews
There are no reviews yet.